| GSK‐J4: An H3K27 histone demethylase inhibitor, as a potential anti‐cancer agent N Dalpatraj, A Naik, N Thakur International Journal of Cancer 153 (6), 2023 | 12 | 2023 |
| TGF-β at the crossroads of multiple prognosis in breast cancer, and beyond N Shukla, A Naik, K Moryani, M Soni, J Shah, H Dave Life sciences 310, 121011, 2022 | 7 | 2022 |
| Combination Treatment of a Phytochemical and a Histone Demethylase Inhibitor—A Novel Approach towards Targeting TGFβ-Induced EMT, Invasion, and Migration in Prostate Cancer N Dalpatraj, A Naik, N Thakur International Journal of Molecular Sciences 24 (3), 1860, 2023 | 5 | 2023 |
| Global Histone H3 lysine 4 trimethylation (H3K4me3) landscape changes in response to TGFβ A Naik, N Dalpatraj, N Thakur Epigenetics Insights 14, 25168657211051755, 2021 | 4 | 2021 |
| Hesperetin modulates TGFβ induced metastatic potential of prostate cancer cells by altering histone methylation marks N Dalpatraj, J Tak, A Naik, N Thakur Advances in Cancer Biology-Metastasis 6, 100077, 2022 | 3 | 2022 |
| Global Gene Expression Regulation Mediated by TGFβ Through H3K9me3 Mark A Naik, N Dalpatraj, N Thakur Cancer Informatics 21, 11769351221115135, 2022 | 2 | 2022 |
| Comparative analysis of the occupancy of Histone H3 Lysine 4 methylation in the cells treated with TGFβ and Interferonγ A Naik, N Dalpatraj, N Thakur Gene 879, 147601, 2023 | | 2023 |
